Evolution and current status of the Whipple procedure: An update for gastroenterologists

被引:105
作者
Strasberg, SM [1 ]
Drebin, JA [1 ]
Soper, NJ [1 ]
机构
[1] WASHINGTON UNIV, DEPT SURG, SECT HEPATOBILARY PANCREAT & GASTROINTESTINAL SUR, ST LOUIS, MO USA
关键词
D O I
10.1016/S0016-5085(97)70195-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The Whipple procedure has undergone a remarkable gradual evolution in the last 20 years, of which many gastroenterologists are unaware. improvements in staging, particularly staging laparoscopy with ultrasonography, have reduced the incidence of negative laparotomies. The forbidding mortality of pancreaticoduodenectomy, approximately 20% just a generation ago, has decreased precipitously in high-volume referral centers. Near zero mortality rates are now common. Morbidity and length of stay have also been reduced. Cardiac and pulmonary complications have been markedly reduced, whereas others such as pancreatic fistula still remain a problem. Modifications of the procedure have been introduced to improve long-term outcome of pancreatic cancer and to lessen digestive sequelae. Total pancreatectomy and large regional excisions did not improve results, However, 5-year survival rates of 20% are now reported by several centers for adenocarcinoma of the pancreas, and long-term survival rates for other periampullary tumors are approximately 40%. Pylorus-sparing procedures can be performed and may lessen postoperative sequelae. The clinical consequences of improved results are that large numbers of procedures are being performed at specialty centers, providing the opportunity to perform clinical trials, and that the procedure is used more widely, for instance, in benign diseases such as chronic pancreatitis.
引用
收藏
页码:983 / 994
页数:12
相关论文
共 77 条
  • [1] ANDERSEN HB, 1994, J AM COLL SURGEONS, V179, P545
  • [2] [Anonymous], 1987, Cancer, V59, P2006
  • [3] BJORK KJ, 1990, ARCH SURG-CHICAGO, V125, P961
  • [4] Blackstock A W, 1996, Oncology (Williston Park), V10, P301
  • [5] BOCKMAN DE, 1988, GASTROENTEROLOGY, V94, P1459
  • [6] TOTAL PANCREATECTOMY FOR DUCTAL CELL-CARCINOMA OF THE PANCREAS - AN UPDATE
    BROOKS, JR
    BROOKS, DC
    LEVINE, JD
    [J]. ANNALS OF SURGERY, 1989, 209 (04) : 405 - 410
  • [7] RANDOMIZED TRIAL OF DUODENUM-PRESERVING PANCREATIC HEAD RESECTION VERSUS PYLORUS-PRESERVING WHIPPLE IN CHRONIC-PANCREATITIS
    BUCHLER, MW
    FRIESS, H
    MULLER, MW
    WHEATLEY, AM
    BEGER, HG
    [J]. AMERICAN JOURNAL OF SURGERY, 1995, 169 (01) : 65 - 70
  • [8] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
    Burris, HA
    Moore, MJ
    Andersen, J
    Green, MR
    Rothenberg, ML
    Madiano, MR
    Cripps, MC
    Portenoy, RK
    Storniolo, AM
    Tarassoff, P
    Nelson, R
    Dorr, FA
    Stephens, CD
    VanHoff, DD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2403 - 2413
  • [9] FACTORS INFLUENCING SURVIVAL AFTER PANCREATICODUODENECTOMY FOR PANCREATIC-CANCER
    CAMERON, JL
    CRIST, DW
    SITZMANN, JV
    HRUBAN, RH
    BOITNOTT, JK
    SEIDLER, AJ
    COLEMAN, J
    [J]. AMERICAN JOURNAL OF SURGERY, 1991, 161 (01) : 120 - 125
  • [10] 100 AND 45 CONSECUTIVE PANCREATICODUODENECTOMIES WITHOUT MORTALITY
    CAMERON, JL
    PITT, HA
    YEO, CJ
    LILLEMOE, KD
    KAUFMAN, HS
    COLEMAN, J
    HERRINGTON, JL
    MASON, GR
    BRADLEY, EL
    JORDAN, GL
    GADACZ, TR
    VANHEERDEN, JA
    WATKINS, GH
    COPELAND, EH
    [J]. ANNALS OF SURGERY, 1993, 217 (05) : 430 - 438